生物来源
rabbit
偶联物
unconjugated
抗体形式
culture supernatant
抗体产品类型
primary antibodies
克隆
EP356, monoclonal
描述
(For In Vitro Diagnostic Use in Select Regions (See Chart))
表单
buffered aqueous solution
种属反应性
human
包装
bottle of 1.0 mL predilute (441R-17)
bottle of 7.0 mL predilute (441R-18)
vial of 0.1 mL concentrate (441R-14)
vial of 0.5 mL concentrate (441R-15)
vial of 1.0 mL concentrate (441R-16)
制造商/商品名称
Cell Marque®
技术
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:50-1:200
同位素/亚型
IgG
运输
wet ice
储存温度
2-8°C
基因信息
human ... NKX3-1(4824)
一般描述
NKX3.1 is a prostate-specific androgen-regulated homeobox gene located on chromosome8p.1-2 NKX3.1 expression is seen in benign and malignant prostate epithelium. NKX3.1is a sensitive and specific tissue marker that can be used to help identify prostateadenocarcinoma.
外形
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide.
制备说明
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
分析说明
 IVD |  IVD |  IVD |  RUO |
其他说明
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
NKX3.1 Positive Control Slides, Product No. 441S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
法律信息
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
此项目有
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Rebecca J Asch-Kendrick et al.
Journal of clinical pathology, 67(9), 768-771 (2014-07-06)
NKX3.1 is an androgen-regulated tumour suppressor gene that is downregulated in prostate carcinoma. Immunohistochemistry for NKX3.1 is primarily specific for prostatic-derived tumours and tissue but is reported in a small number of breast carcinomas. NKX3.1 is also shown to inhibit
Ai-Ying Chuang et al.
The American journal of surgical pathology, 31(8), 1246-1255 (2007-08-02)
The histologic distinction between high-grade prostate cancer and infiltrating high-grade urothelial cancer may be difficult, and has significant implications because each disease may be treated very differently (ie, hormone therapy for prostate cancer and chemotherapy for urothelial cancer). Immunohistochemistry of
Bora Gurel et al.
The American journal of surgical pathology, 34(8), 1097-1105 (2010-07-01)
NKX3.1 is a prostatic tumor suppressor gene located on chromosome 8p. Although most studies have shown that staining for NKX3.1 protein is positive in the majority of primary prostatic adenocarcinomas, it has been shown to be downregulated in many high-grade
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持